Leptomeningeal metastases

被引：47

作者：

Demopoulos A. ^{[1
]}

机构：

[1] Department of Neurology, Mem. Sloan Kettering Cancer Center, New York, NY 10019

来源：

Current Neurology and Neuroscience Reports | 2004年 / 4卷 / 3期

关键词：

Leptomeningeal Metastasis; Intrathecal Chemotherapy; Central Nervous System Relapse; Intrathecal Methotrexate; Ommaya Reservoir;

D O I：

10.1007/s11910-004-0039-z

中图分类号：

学科分类号：

摘要：

Leptomeningeal metastasis, also known as neoplastic meningitis, carcinomatous meningitis, and meningeal carcinomatosis, occurs when cancer cells gain access to cerebrospinal fluid pathways, travel to multiple sites within the central nervous system, settle, and grow. This disease has become an increasingly important late complication in oncology as patients survive longer, develop more brain metastases, and newer chemotherapies fail to penetrate the blood-brain barrier. The hallmark of clinical presentation is a cancer patient who complains of focal neurologic dysfunction and is found to have multifocal signs on neurologic examination. The clinical course is relentlessly progressive; treatment is limited and cures are the subject of case reports. This article reviews the clinical course of leptomeningeal metastasis and addresses recent developments in its pathophysiology, diagnosis, and treatment. Copyright © 2004 by Current Science Inc.

引用

页码：196 / 204

页数：8

共 55 条

[1]

Eberth C.J., Zur Entwicklung des Epitheliomas (Cholesteatomas) dur Pia under der Lungs, Virchow's Arch., 49, pp. 51-63, (1870)

[2]

Hayat G., Ehsan T., Selhorst J.B., Manepali A., Magnetic resonance evidence of perineural metastasis, J. Neuroimaging, 5, pp. 122-125, (1995)

[3]

Rosen S.T., Aisner J., Makuch R.W., Et al., Carcinomatous leptomeningitis in small cell lung cancer: A clinicopathologic review of the National Cancer Institute experience, Medicine, 61, pp. 45-53, (1982)

[4]

Olson M.E., Chernik N.L., Posner J.B., Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study, Arch. Neurol., 30, pp. 122-137, (1974)

[5]

Wasserstrom W.R., Glass J.P., Posner J.B., Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients, Cancer, 49, pp. 759-772, (1982)

[6]

Glass J.P., Melamed M., Chernik N.L., Posner J.B., Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology, Neurology, 29, pp. 1369-1375, (1979)

[7]

Arita N., Taneda M., Hayakawa T., Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome, Acta Neurochir. (Wien), 126, pp. 84-92, (1994)

[8]

Pfeifer H., Wassmann B., Hofmann W.K., Et al., Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate, Clin. Cancer Res., 9, pp. 4674-4681, (2003)

[9]

Freeman A.I., Boyett J.M., Glicksman A.S., Et al., Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up, Med. Pediatr. Oncol., 28, pp. 98-107, (1997)

[10]

Kosmas C., Malamos N.A., Tsavaris N.B., Et al., Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer, J. Neurooncol., 56, pp. 265-273, (2002)

← 1 2 3 4 5 6 →